Background: Gestational thrombocytopenia (defined as a platelet count below 150 x 109 /L) occurs in 5% to 10% of pregnancies. Thrombocytopenia is the second leading cause of blood disorders in pregnancy after anemia. A low platelet count is often an incidental feature, but it might also provide a biomarker of a coexisting systemic or gestational disorder. Timely analysis is needed to determine the primary cause of thrombocytopenia, and appropriate therapy should then be selected to effectively improve the prognosis of the pregnancy. Hypertensive disorders accounts for 33% of all the cases of thrombocytopenia in pregnancy. Methods: The study was conducted at a tertiary institute over a period of one year, from April 2020 to March 2021. This is a retrospective study of indoor patients admitted with the low platelets in the department of obstetrics and gynecology at Smt. Kashibai Navale Medical College and General Hospital. All Pregnant women with platelet count less than 150 x 109 /L were included in the study. Results: Most of the cases presented during 34-38 weeks of gestation. The most common etiology of thrombocytopenia at our place was found to be pregnancy induced hypertension. Conclusions: Thrombocytopenia in pregnancy may occur secondary to a variety of causes. Most of these cases occur during specific periods of gestation. Thrombocytopenia in pregnancy if timely diagnosed do not cause any mortality, however management of these patients require a multidisciplinary approach and close collaboration between obstetrician, physician, and neonatologist.